Anastrozole : interactions médicamenteuses

Anastrozole (Arimidex), inhibiteur de l'aromatase, présente 27 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 17 de niveau majeur, 0 de niveau modéré, 0 de niveau mineur et 10 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.

À quoi ressemble Anastrozole

Voir les 9 versions
Anastrozole 1 mg en comprimé : blanc, rond, 6 mm, inscription Adx sur une face et 1 sur l'autre.
Adx / 1
1 mg · blanc · rond · 6 mm
ANI
Anastrozole 1 mg en comprimé : blanc, rond, 6 mm, inscription A7.
A7
1 mg · blanc · rond · 6 mm
BluePoint
Anastrozole 1 mg en comprimé : blanc, rond, 6 mm, inscription AN sur une face et 1 sur l'autre.
AN / 1
1 mg · blanc · rond · 6 mm
Breckenridge
Anastrozole 1 mg en comprimé : blanc, rond, 6 mm, inscription YL sur une face et 111 sur l'autre.
YL / 111
1 mg · blanc · rond · 6 mm
Yiling

Rendus réalisés à partir des fiches produit des notices FDA : couleur, forme, taille et inscription. 9 versions documentées chez 15 laboratoires.

Interactions d'après la notice

Interactions majeures (17)

  • Désogestrel et éthinylestradiolcontraceptif oralMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Drospirénone et éthinylestradiolcontraceptif oralMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • EstradiolestrogèneMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estradiol et diénogestcontraceptif oralMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estrogènes conjuguésestrogèneMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • FulvestrantestrogèneMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Lévonorgestrel et éthinylestradiolcontraceptif oralMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Norgestimate et éthinylestradiolcontraceptif oralMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Norgestrel et éthinylestradiolcontraceptif oralMajeure

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (notice Anastrozole, Interactions médicamenteuses)

  • Tamoxifènemodulateur sélectif des récepteurs aux estrogènesMajeure

    • Tamoxifen: Do not use in combination with ARIMIDEX. (notice Anastrozole, Interactions médicamenteuses)

Aucune interaction significative signalée (10)

  • ApixabananticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • ArgatrobananticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • BivalirudineanticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • DabigatrananticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • ÉdoxabananticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • ÉnoxaparineanticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • FondaparinuxanticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • HéparineanticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • RivaroxabananticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

  • WarfarineanticoagulantAucune interaction

    Warfarin In a study conducted in 16 male volunteers, anastrozole did not alter the exposure (as measured by C max and AUC) and anticoagulant activity (as measured by prothrombin time, activated partial thromboplastin time, and thrombin time) of both R- and S-warfarin. (notice Anastrozole, Interactions médicamenteuses)

Vérifiez Anastrozole avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.

Ouvrir dans le vérificateur

Ceci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.